Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. (MEDXF) Stock Overview
Explore Medexus Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
91.2M
P/E Ratio
-334.30
EPS (TTM)
$-0.02
ROE
-0.01%
MEDXF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medexus Pharmaceuticals Inc. (MEDXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.38.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -334.30 and a market capitalization of 91.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.